We welcome new client Vertex Pharmaceuticals Inc. of Cambridge, Mass. Vertex's focus is on the discovery and development of breakthrough small molecule drugs for serious diseases, with a product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.